PatelS, JohnAM, HandlerMZ, et al.Fixed drug eruptions: An update, emphasizing the potentially lethal generalized bullous fixed drug eruption. Am J Clin Dermatol, 2020; 21(3):393–399; doi: 10.1007/s40257-020-00505-3
2.
ChoY-T, L J-W, ChenY-C, et al.Generalized bullous fixed drug eruption is distinct from Stevens-Johnson syndrome/toxic epidermal necrolysis by immunohistopathological features. J Am Acad Dermatol, 2014; 70(3):539–548; doi: 10.1016/j.jaad.2013.11.015
3.
PrietoA, De BarrioM, InfanteS, et al.Recurrent fixed drug eruption due to metronidazole elicited by patch test with tinidazole. Contact Dermatitis, 2005; 53(3):169–170; doi:10.1111/j.0105-1873.2005.0407a.x
4.
LipowiczS, SekulaP, Ingen-Housz-OroS, et al.Prognosis of generalized bullous fixed drug eruption: comparison with Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol, 2013; 168(4):726–732; doi: 10.1111/bjd.12133
